Foamix

FOMX NASDAQ
2.985
-0.115
-3.70%
交易中 10:34 08/19 EDT
开盘
3.220
昨收
3.100
最高
3.250
最低
2.930
成交量
26.34万
成交均量(3M)
54.55万
52周最高
7.60
52周最低
1.970
换手率
0.43%
市值
1.82亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Foamix FOMX股票价格,Foamix股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Foamix Pharmaceuticals Ltd. is a clinical-stage pharmaceutical company. The Company is engaged in the development and commercialization of foam-based formulations, using its technology, which includes its foam platforms. It is focused on developing and commercializing its minocycline foam for the treatment of acne, rosacea and other skin conditions. Its product candidates include FMX101, FMX102, FMX103 and FDX104. Its lead product candidate, FMX101, is a topical foam formulation of the antibiotic minocycline for the treatment of moderate-to-severe acne. FMX102 is a formulation of its minocycline foam being developed for the treatment of impetigo. FMX103 is a topical foam formulation of minocycline for the treatment of moderate-to-severe Papulopustular rosacea. FDX104 is a topical foam formulation of the antibiotic doxycycline for the treatment of severe acne-like rashes induced by chemotherapy. It has conducted one Phase II clinical trial for each of FMX101, FMX102, FMX103 and FDX104.
展开 >

最近浏览

名称
价格
涨跌幅